Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,940 total articles

Bayer: Cheap Price, Heavy Debt - A Tactical Long with Clear Guardrails

Bayer: Cheap Price, Heavy Debt - A Tactical Long with Clear Guardrails

Bayer remains a story of two forces: a depressed equity multiple driven by legacy acquisition debt and legal overhangs, and a diversified business with cash-generating pharma and crop-science franchises. We outline a mid-term tactical long with precise entry, target and stop-loss levels that balance upside from normalization with downside protectio…

Deckers: Cash, Category Share, and a Clear Path Higher

Deckers: Cash, Category Share, and a Clear Path Higher

Deckers (DECK) is trading at a reasonable multiple, sitting on strong free cash flow and benefiting from durable brand momentum at HOKA and UGG. With Nike's execution problems leaving openings in running and lifestyle categories, Deckers can accelerate share gains. This is a swing trade idea to capture continued top-line and margin leverage over th…

Butler National: A Small-Cap Aerospace Compounder Poised to Accelerate

Butler National: A Small-Cap Aerospace Compounder Poised to Accelerate

Butler National (BUKS) is a niche aerospace and services issuer showing accelerating revenue and margin expansion driven by Avcon and Butler-Tempe. Recent FAA Supplemental Type Certificates and a $37.0M backlog create a clear revenue runway. This trade idea lays out entry, stop and target for a long trade over a 180-trading-day horizon while highli…

Stitch Fix Is Finding Its Footing: A Mid-Trade Buy on Stabilization

Stitch Fix Is Finding Its Footing: A Mid-Trade Buy on Stabilization

Stitch Fix's latest quarter (reported 06/11/2026) shows revenue growth, rising revenue per client and a narrowed loss. With roughly $229M of cash, positive free cash flow and management buybacks in motion, the fundamentals point to stabilization. Technicals and short interest still create volatility, but a controlled long trade from $3.55 with a $2…

Buy RPM on Durable Maintenance Demand and Margin Tailwinds

Buy RPM on Durable Maintenance Demand and Margin Tailwinds

RPM International reported a blowout Q3 with $1.608B in revenue and record adjusted EBIT, validating a thesis that steady maintenance-driven end markets plus margin expansion will carry results near-term. At a $13.4B market cap and P/E ~20, the stock offers asymmetric upside if RPM sustains operating leverage and free cash flow conversion. This is …

Nebius Positioned to Capture the Open-Source AI Infrastructure Wave

Nebius Positioned to Capture the Open-Source AI Infrastructure Wave

Nebius (NBIS) combines large-scale GPU infrastructure, an AI-centric cloud platform, and data/edge brands that make it a direct beneficiary of the shift toward open-source AI. With a $55.3B market cap, visible revenue momentum and major enterprise contracts, the stock looks actionable on a disciplined long plan: entry $220.00, stop $190.00, target …

LendingTree: Deep Value Entry as New Leadership Normalizes

LendingTree: Deep Value Entry as New Leadership Normalizes

LendingTree is trading at single-digit multiples despite strong profitability, free cash flow and accelerated revenue growth. We like a long position at $45.36 with a $65 target over the next 180 trading days, and a $40 stop. The trade banks on valuation rerating, stabilization under CEO Scott Peyree and continued demand across home, consumer and i…

Nano Labs (NA): Cheap AI-Chip Exposure with a Near-Term Re-rating Path

Nano Labs (NA): Cheap AI-Chip Exposure with a Near-Term Re-rating Path

Nano Labs is a small, Hangzhou-based fabless chip designer focused on high-throughput and vision computing chips and distributed computing solutions. The stock is trading at a market cap near $46M with a PE of ~2.1 and PB ~0.43. Management has signaled intent to pursue North America AI infrastructure via a recent MoU, and the CEO has been a materia…

Acrivon: Small Market Cap, Big Binary Risk - a Tactical Short

Acrivon: Small Market Cap, Big Binary Risk - a Tactical Short

Acrivon Therapeutics (ACRV) sits at roughly a $84M market cap with an enterprise value near $50M, negative EPS (-$1.81) and steep free cash flow burn (-$66.3M). The company’s AP3 precision platform and a 62.5% OncoSignature-positive ORR in endometrial cancer are real positives, but the stock is vulnerable to dilution, trial execution risk and senti…